Germany's public spending ratio - which tracks government expenditure against gross national product - rose to 49.5% in 2024, ...

Most of the top-performing posts analysed were found to contain misinformation, according to social media researchers.

March 10, 2025 BioNTech guides for worse-than-expected 2025 revenue decline German COVID-19 vaccine maker BioNTech on Monday said that its 2025 revenues would likely fall to between 1.7 billion ...

BIONTECH: The German COVID-19 vaccine maker said on March 10 it planned to cut between 950 and 1,350 full-time positions by 2027, including at its late-stage mRNA manufacturing site in Marburg ...

The crisis appears to have done little to change support for “vaccine choice.” Signs in English, Spanish and German inform people ... of whether it’s the COVID pandemic, whether there ...

Paraguayan authorities have deported a German family of 17 people who were all unvaccinated against COVID-19 ... having taken at least two doses of vaccine. Migrations Director Ángeles Arriola ...

Pfizer slashed its production targets for its COVID-19 vaccine because ... expects to produce 50 million doses of the vaccine it developed with the German BioNTech, down from an earlier target ...

Multisystem inflammatory syndrome in children (MIS-C) linked to COVID-19 is associated with ... deputy scientific director of the German Rheumatology Research Center in Berlin, Germany, and ...

BNT111 is a key part of the German biotech's pipeline and development strategy as it responds to declining sales of its Pfizer-partnered COVID-19 vaccines, and returns to its pre-2019, primary ...

A new global pandemic treaty drafted by the World Health Organization (WHO) will help prevent the spread of deadly viruses such as the coronavirus in future, German Health Minister Karl Lauterbach has ...

German company BioNTech closed 7% lower ... thanks largely to its Comirnaty Covid-19 vaccine and Paxlovid antiviral pill – the boom subsided by early 2023, and the company slashed its ...